Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products

Addiction

Volumn 115, Issue 6, 2020, Pages 1141-1148

  Hajek, Peter ^a   Pittaccio, Kate ^a   Pesola, Francesca ^b   Myers Smith, Katie ^a   Phillips Waller, Anna ^a   Przulj, Dunja ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

E cigarettes; Juul; nicotine; nicotine delivery; pharmacokinetic; tobacco

Indexed keywords

NICOTINE;

ADULT; BLOOD; ELECTRONIC CIGARETTE; EUROPEAN UNION; FEMALE; HUMAN; MALE; SMOKING; SMOKING CESSATION; TOBACCO; UNITED KINGDOM; UNITED STATES; VAPING;

ADULT; ELECTRONIC NICOTINE DELIVERY SYSTEMS; EUROPEAN UNION; FEMALE; HUMANS; MALE; NICOTINE; SMOKERS; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; UNITED KINGDOM; UNITED STATES; VAPING;

EID: 85078675804     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.14936     Document Type: Article

References (31)

1. King B. A., Gammon D. G., Marynak K. L., Rogers T. Electronic cigarette sales in the United States, 2013–2017. JAMA 2018; 320: 1379–1380.
2. Kavuluru R., Han S., Hahn E. J. On the popularity of the USB flash drive-shaped electronic cigarette Juul. Tob Control 2019; 28: 110–112.
3. Hammond D., Wackowski O. A., Reid J. L., O’Connor R. J., International Tobacco Control Policy Evaluation Project (ITC) team Use of JUUL e-cigarettes among youth in the United States. Nicotine Tob Res 2018. doi: 10.1093/ntr/nty237.
4. Vallone D. M., Bennett M., Xiao H., Pitzer L., Hair E. C. Prevalence and correlates of JUUL use among a national sample of youth and young adults. Tob Control 2019; 28: 603–609.
5. Cantrell J., Vallone D., Hair E., Huang J., Greenberg M., Willett J. History and current trends in the electronic cigarette retail marketplace in the United States: 2010–2016. Nicotine Tob Res 2018. doi: 10.1093/ntr/nty214.
6. Caldwell B., Sumner W., Crane J. J. N., Research T. A systematic review of nicotine by inhalation: is there a role for the inhaled route? Nicotine Tob Res 2012; 14: 1127–1139.
7. Hajek P., Etter J. F., Benowitz N., Eissenberg T., McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014; 109: 1801–1810.
8. Wonnacott S., Russell M. A. H., Stolerman I. P. Nicotine psychopharmacology: Molecular, cellular, and behavioural aspects. Cary, NC: Oxford University Press; 1990.
9. Hajek P., Przulj D., Phillips A., Anderson R., McRobbie H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology 2017; 234: 773–779.
10. Hajek P., McRobbie H., Gillison F. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med 2007; 44: 230–234.
11. West R., Hajek P., Foulds J., Nilsson F., May S., Meadows A. J. P. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 2000; 149: 198–202.
12. Hajek P., Jackson P., Belcher M. Long-term use of nicotine chewing gum: occurrence, determinants, and effect on weight gain. JAMA 1988; 260: 1593–1596.
13. Hajek P., Phillips-Waller A., Przulj D., Pesola F., Myers Smith K., Bisal N., et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019; 380: 629–637.
14. Birge M., Duffy S., Miler J. A., Hajek P. J. N., Research T. What proportion of people who try one cigarette become daily smokers? A meta analysis of representative surveys. Nicotine Tob Res 2017; 20: 1427–1433.
15. Bauld L., MacKintosh A. M., Ford A., McNeill A. J. N., Research T. E-cigarette uptake amongst UK youth: experimentation, but little or no regular use in nonsmokers. Nicotine Tob Res 2015; 18: 102–103.
16. McNeill A., Brose L. S., Calder R., Bauld L., Robson D. Vaping in England: an evidence update February 2019. A report commissioned by Public Health England. London: Public Health England; 2019.
17. Barrington-Trimis J. L., Leventhal A. M. Adolescents’ use of ‘pod mod’ E-cigarettes—urgent concerns. N Engl J Med 2018; 379: 1099–1102.
18. Cohen G., Mehoudar P., Carbonara C., Wynne C. Acute use of nicotine salt-based ENDS and combusted cigarettes. Society for Research on Nicotine and Tobacco Annual Meeting, Madison, WI, USA; 2018.
19. Hajek P., Przulj D., Phillips-Waller A., Anderson R., McRobbie H. Initial ratings of different types of e-cigarettes and relationships between product appeal and nicotine delivery. Psychopharmacology 2018; 235: 1083–1092.
20. Jacob P. III, Yu L., Duan M., Ramos L., Yturralde O., Benowitz N. L. Determination of the nicotine metabolites cotinine and trans-3′-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography–tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B 2011; 879: 267–276.
21. Taylor J., Triggle D. Comprehensive medicinal chemistry II. New York, NY: Elsevier; 2007.
22. Zhang Y., Huo M., Zhou J., Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel. Comput Methods Programs Biomed 2010; 99: 306–314.
23. Gabrielsson J., Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Stockholm. Sweden: Swedish Pharmaceutical Press; 2000.
24. Stead L. F., Perera R., Bullen C., Mant D., Hartmann-Boyce J., Cahill K. et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 11: CD000146.
25. Schuh K. J., Schuh L. M., Henningfield J. E., Stitzer M. L. J. P. Nicotine nasal spray and vapor inhaler: abuse liability assessment. Psychopharmacology 1997; 130: 352–361.
26. Nemeth-Coslett R., Henningfield J., O'Keeffe M., Griffiths R. R. Nicotine gum: dose-related effects on cigarette smoking and subjective ratings. Psychopharmacology 1987; 92: 424–430.
27. Hoffman A. C., Evans S. E. J. N., Research T. Abuse potential of non-nicotine tobacco smoke components: acetaldehyde, nornicotine, cotinine, and anabasine. Nicotine Tob Res 2012; 15: 622–632.
28. Hogg R. C. J. N., Research T. Contribution of monoamine oxidase inhibition to tobacco dependence: a review of the evidence. Nicotine Tob Res 2015; 18: 509–523.
29. Przulj D., McRobbie H., Hajek P. Effects of nicotine-free E-cigarettes on urges to smoke and cigarette withdrawal symptoms: a randomised cross-over study. J Addict Res Ther 2016; 7. doi: 10.4172/2155-6105.1000259.
30. Rosen L. J., Galili T., Kott J., Goodman M., Freedman L. S. J. A. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Addiction 2018; 113: 805–816.
31. Hajek P. The development and testing of new nicotine replacement treatments: from ‘nicotine replacement’ to ‘smoking replacement’. Addiction 2015; 110: 19–22.